Mobile CRISPR-Cas9 based anti-phage system in E. coli

Abstract

Escherichia coli is one of the most important microbial cell factories, but infection by bacteriophages in the environment may have a huge impact on its application in industrial production. Here, we developed a mobile CRISPR-Cas9 based anti-phage system for bacteriophages defense in E. coli. Two conjugative plasmids pGM1 (phosphoglucomutase 1) and pGM2 carrying one and two guide RNAs, respectively, were designed to defend against a filamentous phage. The results showed that the pGM1 and pGM2 could decrease the phage infection rate to 1.6% and 0.2% respectively in infected cells. For preventing phage infection in E. coli, the pGM2 decreased the phage infection rate to 0.1%, while pGM1 failed to block phage infection. Sequence verification revealed that point mutations in protospacer or protospacer adjacent motif sequences of the phage genome caused loss of the defense function. These results support the potential application of MCBAS in E. coli cell factories to defend against phage infections.

Graphical abstract

Keywords

phage infections / anti-phage / CRISPR-Cas9 / conjugative transfer / synthetic biology

References

[1] Li J, Neubauer P. Escherichia coli as a cell factory for heterologous production of nonribosomal peptides and polyketides. New Biotechnology, 2014, 31(6): 579–585

[2] Baeshen N A, Baeshen M N, Sheikh A, Bora R S, Ahmed M M M, Ramadan H A I, Saini K S, Redwan E M. Cell factories for insulin production. Microbial Cell Factories, 2014, 13(1): 141

[3] Wang Z, Sun J, Yang Q, Yang J. Metabolic engineering Escherichia coli for the production of lycopene. Molecules (Basel, Switzerland), 2020, 25(14): 3136

[4] Lemuth K, Steuer K, Albermann C. Engineering of a plasmid-free Escherichia coli strain for improved in vivo biosynthesis of astaxanthin. Microbial Cell Factories, 2011, 10(1): 29

[5] Li M, Nian R, Xian M, Zhang H. Metabolic engineering for the production of isoprene and isopentenol by Escherichia coli. Applied Microbiology and Biotechnology, 2018, 102(18): 7725–7738

[6] Zhao C, Zhang Y, Li Y. Production of fuels and chemicals from renewable resources using engineered Escherichia coli. Biotechnology Advances, 2019, 37(7): 107402

[7] Wu H, Fan Z, Jiang X, Chen J, Chen G. Enhanced production of polyhydroxybutyrate by multiple dividing E. coli. Microbial Cell Factories, 2016, 15(1): 128

[8] Chen G, Jiang X. Engineering bacteria for enhanced polyhydroxyalkanoates (PHA) biosynthesis. Synthetic and Systems Biotechnology, 2017, 2(3): 192–197

[9] Liu X, Hua K, Liu D, Wu Z, Wang Y, Zhang H, Deng Z, Pfeifer B A, Jiang M. Heterologous biosynthesis of type II polyketide products using E. coli. ACS Chemical Biology, 2020, 15(5): 1177–1183

[10] Tang Y, Wang M, Qin H, An X, Guo Z, Zhu G, Zhang L, Chen Y. Deciphering the biosynthesis of TDP-β-L-oleandrose in avermectin. Journal of Natural Products, 2020, 83(10): 3199–3206

[11] Jones D T, Shirley M, Wu X Y, Keis S. Bacteriophage infections in the industrial acetone butanol (AB) fermentation process. Journal of Molecular Microbiology and Biotechnology, 2000, 2(1): 21–26

[12] Chaturongakul S, Ounjai P. Phage-host interplay: examples from tailed phages and Gram-negative bacterial pathogens. Frontiers in Microbiology, 2014, 5: 442

[13] Kronheim S, Daniel I M, Duan Z, Hwang S, Wong A I, Mantel I, Nodwell J R, Maxwell K L. A chemical defence against phage infection. Nature, 2018, 564(7735): 283–286

[14] Abedon S T. Bacteriophage secondary infection. Virologica Sinica, 2015, 30(1): 3–10

[15] Hampton H G, Watson B N J, Fineran P C. The arms race between bacteria and their phage foes. Nature, 2020, 577(7790): 327–336

[16] Scholl D, Adhya S, Merril C. Escherichia coli K1's capsule is a barrier to bacteriophage T7. Applied and Environmental Microbiology, 2005, 71(8): 4872–4874

[17] Vasu K, Nagaraja V. Diverse functions of restriction-modification systems in addition to cellular defense. Microbiology and Molecular Biology Reviews, 2013, 77(1): 53–72

[18] Pleska M, Guet C C. Effects of mutations in phage restriction sites during escape from restriction- modification. Biology Letters, 2017, 13(12): 20170646

[19] Zhou Y, Xu X, Wei Y, Cheng Y, Guo Y, Khudyakov I, Liu F, He P, Song Z, Li Z, . A widespread pathway for substitution of adenine by diaminopurine in phage genomes. Science, 2021, 372(6541): 512–516

[20] Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero D A, Horvath P. CRISPR provides acquired resistance against viruses in prokaryotes. Science, 2007, 315(5819): 1709–1712

[21] Smith G P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science, 1985, 228(4705): 1315–1317

[22] Esvelt K M, Carlson J C, Liu D R. A system for the continuous directed evolution of biomolecules. Nature, 2011, 472(7344): 499–550

[23] Carlson J C, Badran A H, Guggiana N D A, Liu D R. Negative selection and stringency modulation in phage-assisted continuous evolution. Nature Chemical Biology, 2014, 10(3): 216–222

[24] Bryson D I, Fan C, Guo L, Miller C, Soll D, Liu D R. Continuous directed evolution of aminoacyl-tRNA synthetases. Nature Chemical Biology, 2018, 14(2): 186

[25] de Leeuw M, Baron M, David O B, Kushmaro A. Molecular insights into bacteriophage evolution toward its host. Viruses, 2020, 12(10): 1132

[26] Chayot R, Montagne B, Mazel D, Ricchetti M. An end-joining repair mechanism in Escherichia coli. Proceedings of the National Academy of Sciences of the United States of America, 2010, 107(5): 2141–2146

[27] Liu L, Zhao D, Ye L, Zhan T, Xiong B, Hu M, Bi C, Zhang X. A programmable CRISPR/Cas9-based phage defense system for Escherichia coli BL21(DE3). Microbial Cell Factories, 2020, 19(1): 136

[28] Dong H, Xiang H, Mu D, Wang D, Wang T. Exploiting a conjugative CRISPR/Cas9 system to eliminate plasmid harbouring the mcr-1 gene from Escherichia coli. International Journal of Antimicrobial Agents, 2019, 53(1): 1–8

[29] Xie Z X, Li B Z, Mitchell L A, Wu Y, Qi X, Jin Z, Jia B, Wang X, Zeng B X, Liu H M, . “Perfect” designer chromosome V and behavior of a ring derivative. Science, 2017, 355(6329): 1046

[30] Wu Y, Li B Z, Zhao M, Mitchell L A, Xie Z X, Lin Q H, Wang X, Xiao W H, Wang Y, Zhou X, . Bug mapping and fitness testing of chemically synthesized chromosome X. Science, 2017, 355(6329): 1048

[31] Chen W G, Han M Z, Zhou J T, Ge Q, Wang P P, Zhang X C, Zhu S Y, Song L F, Yuan Y J. An artificial chromosome for data storage. National Science Review, 2021, 8(5): 62–70

[32] Wang L, Jiang S, Chao C, He W, Wu X, Wang F, Tong T, Zou X, Li Z, Luo J, . Synthetic genomics: from DNA synthesis to genome design. Angewandte Chemie International Edition, 2018, 57(7): 1748–1756

[33] Cello J, Paul A V, Wimmer E. Chemical synthesis of poliovirus cDNA: generation of infectious virus in the absence of natural template. Science, 2002, 297(5583): 1016–1018

[34] Smith H O, Iii C A H, Pfannkoch C, Venter J C. Generating a synthetic genome by whole genome assembly: X174 bacteriophage from synthetic oligonucleotides. Proceedings of the National Academy of Sciences of the United States of America, 2003, 100(26): 15440–15445

[35] Chan L Y, Kosuri S, Endy D.Refactoring bacteriophage T7. Molecular Systems Biology, 2005, 1: 2005.0018

[36] Thao T, Labroussaa F, Ebert N, Kovski P V, Thiel V. Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. Nature, 2020, 582(7813): 561–565

[37] Zhang J, Zhang D, Zhu J, Liu H, Liang S, Luo Y. Efficient multiplex genome editing in Streptomyces via engineered CRISPR-Cas12a systems. Frontiers in Bioengineering and Biotechnology, 2020, 8: 726

[38] Wang L, Wang H, Liu H, Zhao Q, Liu B, Wang L, Zhang J, Zhu J, Bao R, Luo Y. Improved CRISPR-Cas12a-assisted one-pot DNA editing method enables seamless DNA editing. Biotechnology and Bioengineering, 2019, 116(6): 1463–1474

[39] Liu H, Wang L, Luo Y. Blossom of CRISPR technologies and applications in disease treatment. Synthetic and Systems Biotechnology, 2018, 3(4): 217–228

RIGHTS & PERMISSIONS

Higher Education Press